STOCK TITAN

Boston Scientific (BSX) CFO reports RSU conversion and tax-withheld shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Boston Scientific EVP and CFO Jonathan Monson reported routine equity compensation activity involving restricted stock units. He exercised 2,087 restricted stock units into 2,087 shares of common stock and, in a related tax-withholding disposition, 1,010 shares were withheld at a price of $43.06 per share to cover tax obligations. After these transactions, he directly holds 39,063 shares of common stock and 6,263 restricted stock units, which each represent a commitment by the company to issue one share of common stock in the future, with shares to be issued in four equal annual installments beginning on July 1, 2026.

Positive

  • None.

Negative

  • None.
Insider Monson Jonathan
Role EVP and CFO
Type Security Shares Price Value
Exercise Restricted Stock Units 2,087 $0.00 --
Exercise Common Stock 2,087 $0.00 --
Tax Withholding Common Stock 1,010 $43.06 $43K
Holdings After Transaction: Restricted Stock Units — 6,263 shares (Direct, null); Common Stock — 40,073 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant.
Tax-withheld shares 1,010 shares at $43.06 Shares withheld to satisfy tax liability on 2026-07-01
RSUs exercised 2,087 restricted stock units Converted into common stock on 2026-07-01
Common shares held 39,063 shares Direct ownership after transactions
RSUs outstanding 6,263 restricted stock units Units remaining after reported activity
Restricted Stock Units financial
"security_title: "Restricted Stock Units" and footnote describing each unit as a commitment to issue one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition" for the F-code transaction"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for the M-code transactions"
derivative security financial
"transaction_code_description references "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Monson Jonathan

(Last)(First)(Middle)
300 BOSTON SCIENTIFIC WAY

(Street)
MARLBOROUGH MASSACHUSETTS 01752-1234

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026M2,087A$0.0000(1)40,073D
Common Stock07/01/2026F1,010D$43.0639,063D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)07/01/2026M2,087 (2)07/01/2029(2)Common Stock2,087$0.00006,263D
Explanation of Responses:
1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Boston Scientific (BSX) CFO Jonathan Monson report?

Jonathan Monson reported exercising 2,087 restricted stock units into common shares and a related tax-withholding disposition of 1,010 shares at $43.06 per share. These actions reflect routine equity compensation and tax settlement activity rather than open-market buying or selling.

How many Boston Scientific (BSX) shares does the CFO hold after this Form 4?

After the reported transactions, Jonathan Monson directly holds 39,063 shares of Boston Scientific common stock. He also holds 6,263 restricted stock units, which represent a commitment by the company to issue an equal number of common shares in the future.

What does the tax-withholding disposition in the Boston Scientific (BSX) Form 4 mean?

The tax-withholding disposition shows 1,010 shares withheld at $43.06 per share to satisfy tax liabilities arising from equity vesting. This is not an open-market sale but a mechanism for covering taxes owed when restricted stock units convert into common shares.

How do the restricted stock units reported for Boston Scientific (BSX) CFO vest and settle?

Each restricted stock unit represents a commitment to issue one Boston Scientific common share. According to the disclosure, shares will be issued to Jonathan Monson in four equal annual installments beginning July 1, 2026, aligning equity compensation with multi-year service and performance.

Did the Boston Scientific (BSX) CFO’s Form 4 show open-market buying or selling?

The filing did not show open-market purchases or sales. It reported an exercise of 2,087 restricted stock units into common stock and a related tax-withholding disposition of 1,010 shares, both standard components of equity compensation administration rather than discretionary market trades.